Facial Injectable Market

The Facial Injectable Market is valued at USD 15.3 Bn in 2026 and is projected to reach USD 25.1 Bn, growing at a CAGR of 6% by 2033

Market Analysis in Brief

In 2022, the facial injectable market reflected modest growth and per industry figures, it stood at over US$11 Bn in terms of value. According to preliminary study carried out by Fairfield Market Research, the market will witness promising expansion in the near future.

Growing emphasis on aesthetics has played an important role in building consumer attitudes in favor of the various cosmetic procedures that also include facial injectables. With increasing popularity of dermal fillers like hyaluronic acid, and neurotoxin compounds like botox, the market will remain on an uptrend.

Key Report Findings:

• Rising number if cosmetic procedures to bolster growth of the market
• Increasing participation of male population to give an impetus to the facial injectable market
• North America to account for a significant revenue share in the market
• Asian countries to prevail as the key revenue pockets for facial injectables in the forthcoming years

Growth Drivers

Rising Aesthetic Procedures to Complement Growth of the Facial Injectable Market

The demand for aesthetic procedures has been increasing since past few years despite of economic uncertainties. Post the stress of the COVID 19 pandemic, there was a surge in the aesthetic procedures. For instance, according to the American Society of Plastic Surgeons, individuals in America have been investing in themselves by carrying out cosmetic procedures regardless of uncertain economy. Also, more business was observed in the post-pandemic era as compared to the scenario before the pandemic.

In addition, social media has been playing a critical role in driving the cosmetic business. Millennials of the new generation are more information equipped and have embraced technology. While making changes to their own aesthetics and physical appearance, they have been directly and indirectly promoting the benefits and after-effects of facial aesthetics which has given a considerable momentum to the facial injectable market.

Individuals are also opting for different dermal fillers to enhance their facial aesthetics. This can be backed by rising inclination of people towards self-enrichment coupled with rising awareness of such procedures. Additionally, owing to social media platforms, aesthetic procedures are no longer a taboo and are accessible and relatable. Open sharing of experiences has resulted in individuals being well-versed about aesthetic procedures of their interest. This has resulted in an increase in the number of aesthetic procedures performed worldwide, especially among women population. For instance, according to the International Society of Aesthetic Plastic Surgery, women population accounted for around 86% of the total aesthetic procedures performed in 2020 globally. In this backdrop, rising number of aesthetic procedures is expected to augment the growth of the facial injectable market.

Budding Demand from Male Population

Another crucial factor influencing the facial injectable market is the rising inclination of the male population towards investment in themselves through cosmetics. Owing to age related concerns, adoption of cosmetic procedures among male populace has been increasing in order to maintain their physical aesthetics. As compared to past few decades, the attitude of male population towards cosmetics has transformed significantly and these procedures are being viewed as means of self enhancement. Not confined to sheer toughness and muscle, masculinity has undergone a new transformation with respect to self-aesthetics, and personal care.

According to the International Society of Aesthetic Plastic Surgery, approximately 3.4 million aesthetic procedures were carried out on men in 2020 worldwide. That said, rising demand from male population is poised to contribute towards the value growth of the facial injectable market.

Growth Opportunities Across Regions

North America to Slate Dominance

The value and volume growth of the facial injectable market in North America is poised to increase significantly accounting for a major share from a global perspective. Increasing awareness about novel aesthetic procedures, rising demand for minimally and non-invasive aesthetic surgical procedures and growing technological advancements in the aesthetic and cosmetic sector are few of the factors influencing the market growth in the region.

In addition, other factors such as rising geriatric population coupled with rising GDP per capita and presence of major players from the cosmetic space have also contributed towards the growth of the market in North America. Also, owing to rise in the geriatric population, the demand for dermal fillers has increased significantly, thus complementing the revenue growth of the market.

Furthermore, rising product launches and their approvals from regulatory authorities have also played a major role in driving the expansion of the facial injectable market. For instance, in February 2022, US Food and Drug Administration gave approval to Allergan Aesthetics’s JUVEDERM VOLBELLA XC which is intended towards improving the infraorbital hollows amongst the adult population in the age range of 21 years and above. These factors are expected to pave new avenues for market, thus making North America one the leading regions in this space on the global front.

Asian Markets Emerge as Hotbeds for Facial Injectables

On the other hand, developing nations in Asia Pacific such as China and India are also expected to reflect high growth potential. This is mainly owing to expanding cosmetics sector coupled with huge customer pool backed by growing population in the region. The rate of geriatric population in Asian countries is also increasing at a rapid pace. For instance, according to report by the United Nations, approximately 33% representing more than 400 million people in China are expected to be aged more than 60 years by the end of 2050.

Also, as per Department for Economic and Social Information of the United Nations, collectively more than 0.75 billion people aged 60 years and above would live in India, and China in 2050, which accounts for about 38% of the total aged population falling in this age range on the global front. This is expected to offer lucrative opportunities to the cosmetic sector, in turn providing a strong base for the facial injectable market.

Facial Injectable Market: Competitive Scenario

A few of the major players in the facial injectable market include 

• AbbVie Inc. (Allergan Aesthetics)
• Galderma S.A.
• Merz Pharma GmbH & Co. KGaA
• Ipsen S.A.
• Hugel, Inc.
• Medytox, Inc.
• Sinclair Pharma
• Revance Therapeutics, Inc.
• Teoxane Laboratories
• LG Chem Ltd. (Aesthetics division)
• Anika Therapeutics, Inc.
• Bloomage BioTechnology Corporation
• Croma-Pharma GmbH
• Prollenium Medical Technologies
• Suneva Medical, Inc

Recent Notable Developments

• In August 2022, JUVEDERM VOLUX was launched by Allergan Healthcare India. This is a hyaluronic acid aesthetic filler that facilitates restoration of jawline and chin
• In February 2022, Radiesse was introduced by Merz Pharma. This is an aesthetic injectable that improves moderate to critical loss of the jawline contour
• In February 2021, US FDA approved Galderma’s Restylane Defyne that is used for chin augmentation
• In February 2020, distribution rights of Sinclair Pharma’s Sculptra were offered to Galderma in Europe

Global Facial Injectable Market Segmentation is Described Below:

By Product Type

• Collagen
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylaptite (CaHA)
• Polymer Fillers
• Others

By Generation

• Gen X
• Boomer
• Millennials

By Application

• Aesthetics
• Therapeutics

By End-user

• Hospitals
• Specialty Clinics
• Spa and Beauty Clinics

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa